Oligodendroglioma:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Oligodendroglioma Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Oligodendroglioma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by BRIC Nations 14
Clinical Trials by G7 Nations 15
Clinical Trials in G7 Nations by Trial Status 16
Clinical Trials by E7 Nations 17
Clinical Trials in E7 Nations by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Oligodendroglioma 22
Subjects Recruited Over a Period of Time 25
Prominent Sponsors 26
Top Companies Participating in Oligodendroglioma Therapeutics Clinical Trials 28
Prominent Drug Comparison 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Celgene Corporation 31
Clinical Trial Overview of Celgene Corporation 31
Tocagen Inc. 32
Clinical Trial Overview of Tocagen Inc. 32
Teva Pharmaceutical Industries Limited 33
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 33
Shandong Lanjin Pharmaceuticals Co. Ltd 34
Clinical Trial Overview of Shandong Lanjin Pharmaceuticals Co. Ltd 34
Celldex Therapeutics, Inc. 35
Clinical Trial Overview of Celldex Therapeutics, Inc. 35
Keryx Biopharmaceuticals, Inc. 36
Clinical Trial Overview of Keryx Biopharmaceuticals, Inc. 36
Insys Therapeutics, Inc. 37
Clinical Trial Overview of Insys Therapeutics, Inc. 37
DNAtrix, Inc. 38
Clinical Trial Overview of DNAtrix, Inc. 38
Direct Therapeutics, Inc. 39
Clinical Trial Overview of Direct Therapeutics, Inc. 39
Burzynski Research Institute, Inc. 40
Clinical Trial Overview of Burzynski Research Institute, Inc. 40
Clinical Trial Overview of Top Institutes / Government 41
National Cancer Institute 41
Clinical Trial Overview of National Cancer Institute 41
Memorial Sloan Kettering Cancer Center 45
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 45
Duke University 46
Clinical Trial Overview of Duke University 46
Dana-Farber Cancer Institute, Inc. 47
Clinical Trial Overview of Dana-Farber Cancer Institute, Inc. 47
Radiation Therapy Oncology Group 48
Clinical Trial Overview of Radiation Therapy Oncology Group 48
UCLA’s Jonsson Comprehensive Cancer Center 49
Clinical Trial Overview of UCLA’s Jonsson Comprehensive Cancer Center 49
European Organization for Research and Treatment of Cancer 50
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 50
City of Hope National Medical Center 51
Clinical Trial Overview of City of Hope National Medical Center 51
University of California, San Francisco 52
Clinical Trial Overview of University of California, San Francisco 52
University of Pittsburgh 53
Clinical Trial Overview of University of Pittsburgh 53
Five Key Clinical Profiles 54
Appendix 104
Abbreviations 104
Definitions 104
Research Methodology 105
Secondary Research 105
About GlobalData 105
Contact Us 105
Disclaimer 106
Source 106


【レポート販売概要】

■ タイトル:Oligodendroglioma:グローバル臨床試験レビューH2, 2013
■ 英文:Oligodendroglioma Global Clinical Trials Review, H2, 2013
■ 発行日:2013年11月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162961
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。